HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bill Wondergem Selected Research

Biomarkers (Surrogate Marker)

2/2011FXYD3: A Promising Biomarker for Urothelial Carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bill Wondergem Research Topics

Disease

5Neoplasms (Cancer)
02/2011 - 03/2009
3Renal Cell Carcinoma (Grawitz Tumor)
02/2011 - 05/2009
2Hypoxia (Hypoxemia)
02/2011 - 03/2009
1Carcinoma (Carcinomatosis)
02/2011
1Necrosis
05/2009
1Breast Neoplasms (Breast Cancer)
03/2009
1Carcinogenesis
03/2009
1Disease Progression
03/2009

Drug/Important Bio-Agent (IBA)

3Proteins (Proteins, Gene)FDA Link
02/2011 - 03/2009
1Messenger RNA (mRNA)IBA
02/2011
1Biomarkers (Surrogate Marker)IBA
02/2011
1ubiquitin carrier proteinsIBA
02/2011
1ParaffinIBA
02/2011
1Proteasome Endopeptidase Complex (Proteasome)IBA
02/2011
1Histones (Histone)IBA
01/2010
1ChromatinIBA
01/2010
1Therapeutic UsesIBA
05/2009
1Indicators and Reagents (Reagents)IBA
05/2009
1Angiogenesis InhibitorsIBA
05/2009
1Phosphotransferases (Kinase)IBA
03/2009
1RNA (Ribonucleic Acid)IBA
03/2009
1ErbB Receptors (EGF Receptor)IBA
03/2009
1tyrosine receptor (receptor, tyrosine)IBA
03/2009

Therapy/Procedure

2Therapeutics
05/2009 - 03/2009
1Nephrectomy
02/2011
1Drug Therapy (Chemotherapy)
05/2009
1Radiotherapy
05/2009